Table 12.
Demographics and Clinical Characteristics of Participants With Normal Endothelial Function and Endothelium‐Dependent Dysfunction
| Variable |
Patients* (n=78) |
Controls* (n=30) |
P value |
|---|---|---|---|
| Age, y | 54±10 | 57±9 | 0.839 |
| Female sex | 59 (76) | 24 (80) | 0.634 |
| BMI, kg/m2 | 30±6 | 28±5 | 0.274 |
| Systolic blood pressure, mm Hg | 125±17 | 120 (112; 130) | 0.540 |
| Diastolic blood pressure, mm Hg | 76±9 | 74 (70; 80) | 0.638 |
| Smoking status | |||
| Never smoked | 50 (64) | 17 (57) | 0.800 |
| Former smoker | 24 (31) | 10 (33) | 0.800 |
| Current smoker | 4 (5) | 3 (10) | 0.362 |
| Hypertension | 32 (59) | 15 (50) | 0.404 |
| Diabetes | 10 (13) | 4 (13) | 0.944 |
| Hyperlipidemia | 47 (60) | 14 (47) | 0.206 |
| eGFR, mL/min per 1.73 m2 | 75±15 | 74 (61; 92) | 0.681 |
| Aspirin use | 50 (64) | 19 (63) | 0.941 |
| β‐blocker use | 37 (47) | 9 (30) | 0.103 |
| Lipid‐lowering drug use | 41 (53) | 12 (40) | 0.246 |
| Antihypertensive use | 23 (29) | 11 (37) | 0.476 |
BMI indicates body mass index; and eGFR, estimated glomerular filtration rate.
*
Data are presented as number (percentage), mean±SD, or median (interquartile range).